Literature DB >> 15610500

The IL-12 family member p40 chain as a master switch and novel therapeutic target in psoriasis.

Frank O Nestle1, Curdin Conrad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15610500     DOI： 10.1111/j.0022-202X.2004.23488.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  15 in total

Review 1.  [A decade of biologics in dermatology].

Authors:  G Wozel; M Meurer
Journal:  Hautarzt       Date:  2012-04       Impact factor: 0.751

2.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting.

Authors:  Seemal R Desai; Ilona J Frieden; Joel M Gelfand; Whitney High; Arthur Kavanaugh; Ashfaq A Marghoob; David M Ozog; Ted Rosen; Linda Stein Gold; Bruce Strober; Neil Swanson; George Martin
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

Review 3.  Immunopathogenesis of psoriasis.

Authors:  Brian J Nickoloff; Jian-Zhong Qin; Frank O Nestle
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

4.  IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions.

Authors:  Andrew L Croxford; Susanne Karbach; Florian C Kurschus; Simone Wörtge; Alexei Nikolaev; Nir Yogev; Sabrina Klebow; Rebecca Schüler; Sonja Reissig; Carolin Piotrowski; Elke Brylla; Ingo Bechmann; Jürgen Scheller; Stefan Rose-John; F Thomas Wunderlich; Thomas Münzel; Esther von Stebut; Ari Waisman
Journal:  J Invest Dermatol       Date:  2013-09-25       Impact factor: 8.551

5.  Biologics for psoriasis: a translational research success story.

Authors:  Mark Lebwohl
Journal:  J Invest Dermatol       Date:  2015-05       Impact factor: 8.551

Review 6.  [Pathogenesis of psoriasis].

Authors:  K Schäkel; M P Schön; K Ghoreschi
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

7.  Cutting edge: A critical functional role for IL-23 in psoriasis.

Authors:  Giulia Tonel; Curdin Conrad; Ute Laggner; Paola Di Meglio; Katarzyna Grys; Terrill K McClanahan; Wendy M Blumenschein; Jian-Zhong Qin; Hong Xin; Elizabeth Oldham; Robert Kastelein; Brian J Nickoloff; Frank O Nestle
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

8.  The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.

Authors:  Hans Skvara; Markus Dawid; Elise Kleyn; Barbara Wolff; Josef G Meingassner; Hilary Knight; Thomas Dumortier; Tamara Kopp; Nasanin Fallahi; Georg Stary; Christoph Burkhart; Olivier Grenet; Juergen Wagner; Youssef Hijazi; Randall E Morris; Claire McGeown; Christiane Rordorf; Christopher E M Griffiths; Georg Stingl; Thomas Jung
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

9.  Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice.

Authors:  Immanuel Lerner; Eyal Zcharia; Tzahi Neuman; Esther Hermano; Ariel M Rubinstein; Israel Vlodavsky; Michael Elkin
Journal:  Cell Mol Life Sci       Date:  2013-10-30       Impact factor: 9.261

Review 10.  Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer.

Authors:  Pascale Quatresooz; Trinh Hermanns-Lê; Gérald E Piérard; Philippe Humbert; Philippe Delvenne; Claudine Piérard-Franchimont
Journal:  J Biomed Biotechnol       Date:  2012-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.